^Van Aken O, Pecenkova T, van de Cotte B et al. (2007). “Mitochondrial type-I prohibitins of Arabidopsis thaliana are required for supporting proficient meristem development”. Plant J.52 (5): 850–864. doi:10.1111/j.1365-313X.2007.03276.x. PMID17883375.
^Gamble SC, Chotai D, Odontiadis M, Dart DA, Brooke GN, Powell SM, Reebye V, Varela-Carver A, Kawano Y, Waxman J, Bevan C (March 2007). “Prohibitin, a protein downregulated by androgens, represses androgen receptor activity”. Oncogene26 (12): 1757–68. doi:10.1038/sj.onc.1209967. PMID16964284.
^Kurtev V, Margueron R, Kroboth K, Ogris E, Cavailles V, Seiser C (June 2004). “Transcriptional regulation by the repressor of estrogen receptor activity via recruitment of histone deacetylases”. J. Biol. Chem.279 (23): 24834–43. doi:10.1074/jbc.M312300200. PMID15140878.
^ abJoshi, Bharat; Ko Danette, Ordonez-Ercan Dalia, Chellappan Srikumar P (Dec. 2003). “A putative coiled-coil domain of prohibitin is sufficient to repress E2F1-mediated transcription and induce apoptosis”. Biochem. Biophys. Res. Commun. (United States) 312 (2): 459–66. doi:10.1016/j.bbrc.2003.10.148. ISSN0006-291X. PMID14637159.
^Wang, Sheng; Fusaro Gina, Padmanabhan Jaya, Chellappan Srikumar P (Dec. 2002). “Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repression”. Oncogene (England) 21 (55): 8388–96. doi:10.1038/sj.onc.1205944. ISSN0950-9232. PMID12466959.
^ abcWang, S; Nath N, Adlam M, Chellappan S (Jun. 1999). “Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function”. Oncogene (ENGLAND) 18 (23): 3501–10. doi:10.1038/sj.onc.1202684. ISSN0950-9232. PMID10376528.
^ abFusaro, Gina; Dasgupta Piyali, Rastogi Shipra, Joshi Bharat, Chellappan Srikumar (Nov. 2003). “Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling”. J. Biol. Chem. (United States) 278 (48): 47853–61. doi:10.1074/jbc.M305171200. ISSN0021-9258. PMID14500729.
^Bacher, Susanne; Achatz Gernot, Schmitz M L, Lamers Marinus C (Dec. 2002). “Prohibitin and prohibitone are contained in high-molecular weight complexes and interact with alpha-actinin and annexin A2”. Biochimie (France) 84 (12): 1207–20. doi:10.1016/S0300-9084(02)00027-5. ISSN0300-9084. PMID12628297.
推薦文献
McClung JK, Jupe ER, Liu XT, Dell'Orco RT (1996). “Prohibitin: potential role in senescence, development, and tumor suppression”. Exp. Gerontol.30 (2): 99–124. doi:10.1016/0531-5565(94)00069-7. PMID8591812.
Dell'Orco RT, McClung JK, Jupe ER, Liu XT (1996). “Prohibitin and the senescent phenotype”. Exp. Gerontol.31 (1–2): 245–52. doi:10.1016/0531-5565(95)02009-8. PMID8706794.
Mishra S, Murphy LC, Nyomba BL, Murphy LJ (2005). “Prohibitin: a potential target for new therapeutics”. Trends in molecular medicine11 (4): 192–7. doi:10.1016/j.molmed.2005.02.004. PMID15823758.
Sato T, Saito H, Swensen J et al. (1992). “The human prohibitin gene located on chromosome 17q21 is mutated in sporadic breast cancer”. Cancer Res.52 (6): 1643–6. PMID1540973.
Dawson SJ, White LA (1992). “Treatment of Haemophilus aphrophilus endocarditis with ciprofloxacin”. J. Infect.24 (3): 317–20. doi:10.1016/S0163-4453(05)80037-4. PMID1602151.
White JJ, Ledbetter DH, Eddy RL et al. (1992). “Assignment of the human prohibitin gene (PHB) to chromosome 17 and identification of a DNA polymorphism”. Genomics11 (1): 228–30. doi:10.1016/0888-7543(91)90126-Y. PMID1684951.
Altus MS, Wood CM, Stewart DA et al. (1995). “Regions of evolutionary conservation between the rat and human prohibitin-encoding genes”. Gene158 (2): 291–4. doi:10.1016/0378-1119(95)00164-2. PMID7607556.
Ikonen E, Fiedler K, Parton RG, Simons K (1995). “Prohibitin, an antiproliferative protein, is localized to mitochondria”. FEBS Lett.358 (3): 273–7. doi:10.1016/0014-5793(94)01444-6. PMID7843414.
Maruyama K, Sugano S (1994). “Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides”. Gene138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID8125298.
Sato T, Sakamoto T, Takita K et al. (1993). “The human prohibitin (PHB) gene family and its somatic mutations in human tumors”. Genomics17 (3): 762–4. doi:10.1006/geno.1993.1402. PMID8244394.
Jupe ER, Liu XT, Kiehlbauch JL et al. (1996). “The 3' untranslated region of prohibitin and cellular immortalization”. Exp. Cell Res.224 (1): 128–35. doi:10.1006/excr.1996.0120. PMID8612677.
Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K et al. (1997). “Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library”. Gene200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID9373149.
Rasmussen RK, Ji H, Eddes JS et al. (1998). “Two-dimensional electrophoretic analysis of mixed lineage kinase 2 N-terminal domain binding proteins”. Electrophoresis19 (5): 809–17. doi:10.1002/elps.1150190535. PMID9629920.
Wang S, Nath N, Adlam M, Chellappan S (1999). “Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function”. Oncogene18 (23): 3501–10. doi:10.1038/sj.onc.1202684. PMID10376528.
Coates PJ, Nenutil R, McGregor A et al. (2001). “Mammalian prohibitin proteins respond to mitochondrial stress and decrease during cellular senescence”. Exp. Cell Res.265 (2): 262–73. doi:10.1006/excr.2001.5166. PMID11302691.
Van Aken O, Pecenkova T, van de Cotte B et al. (2007). “Mitochondrial type-I prohibitins of Arabidopsis thaliana are required for supporting proficient meristem development”. Plant J.52 (5): 850–864. doi:10.1111/j.1365-313X.2007.03276.x. PMID17883375.